1. Dongiovanni, Paola, Meroni, Marica, Baselli, Guido, Kozlitina, Julia, Valenti, Luca. 2019. PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients. In Journal of lipid research, 60, 1144-1153. doi:10.1194/jlr.P090449. https://pubmed.ncbi.nlm.nih.gov/30918065/
2. Vargas-Alarcón, Gilberto, Pérez-Méndez, Oscar, González-Pacheco, Héctor, Escobedo, Galileo, Fragoso, José Manuel. 2021. The rs508487, rs236911, and rs236918 Genetic Variants of the Proprotein Convertase Subtilisin-Kexin Type 7 (PCSK7) Gene Are Associated with Acute Coronary Syndrome and with Plasma Concentrations of HDL-Cholesterol and Triglycerides. In Cells, 10, . doi:10.3390/cells10061444. https://pubmed.ncbi.nlm.nih.gov/34207761/
3. Oexle, Konrad, Ried, Janina S, Hicks, Andrew A, Winkelmann, Juliane, Meitinger, Thomas. 2010. Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels. In Human molecular genetics, 20, 1042-7. doi:10.1093/hmg/ddq538. https://pubmed.ncbi.nlm.nih.gov/21149283/
4. Buch, Stephan, Sharma, Aneesh, Ryan, Eleanor, Stickel, Felix, Morgan, Marsha Y. 2021. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis. In Alimentary pharmacology & therapeutics, 53, 830-843. doi:10.1111/apt.16252. https://pubmed.ncbi.nlm.nih.gov/33565643/
5. Malakootian, Mahshid, Naeli, Parisa, Mowla, Seyed Javad, Seidah, Nabil G. 2022. Post-Transcriptional Effects of miRNAs on PCSK7 Expression and Function: miR-125a-5p, miR-143-3p, and miR-409-3p as Negative Regulators. In Metabolites, 12, . doi:10.3390/metabo12070588. https://pubmed.ncbi.nlm.nih.gov/35888711/
6. Huang, Tao, Huang, Jinyan, Qi, Qibin, Sacks, Frank M, Qi, Lu. 2014. PCSK7 genotype modifies effect of a weight-loss diet on 2-year changes of insulin resistance: the POUNDS LOST trial. In Diabetes care, 38, 439-44. doi:10.2337/dc14-0473. https://pubmed.ncbi.nlm.nih.gov/25504030/
智鼠故事 
